D W MCMILLAN MEMORIAL HOSPITAL

Code	Description	Gross	Cash	Min payer	Max payer	# insurers
J9228	IPILIMUMAB 200 MG 40 ML [ECHA]	$172,169	$103,301	—	—	6
988	NONEXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC	$156,383	$93,830	—	—	6
J2350	OCRELIZUMAB 300MG10ML 30MGML 300 MG 10 ML [ECHA]	$97,500	$58,500	—	—	6
J9043	CABAZITAXEL EA ONC 340EAB 60 MG 1 EA [ECHA]	$62,867	$37,720	—	—	5
J3055	talquetamabEAtgvs 40 mgmL Sol[ECHA]	$62,160	$37,296	—	—	4
J9380	TeclistamabEAcqyv 153 mg 1.7 mL Sol	$58,292	$34,975	—	—	4
J9119	cemiplimab 350 mg7 mL Sol [ECHA]	$55,419	$33,251	—	—	5
J1932	lanreotide 120 mg0.5 mL Sol	$53,356	$32,014	—	—	5
J9316	hyaluronidasepertuzumabtrastuzumab 20000 unitsEA600 mgEA600 mg10 mL Sol[ECHA]	$50,826	$30,496	—	—	5
J9042	brentuximab vedotin 50 mg Pow [ECHA]	$47,760	$28,656	—	—	5
J9144	daratumumabEAhyaluronidase 1800 mgEA30000 units15 mL Sol[ECHA]	$45,444	$27,266	—	—	5
J9300	GEMTUZUMAB OZOGAMICIN 5 MG 1 EA [ECHA]	$42,822	$25,693	—	—	0
207	RESPIRATORY SYSTEM DIAGNOSIS WITH VENTILATOR SUPPORT less than96 HOURS	$40,746	$24,447	—	—	6
790	EXTREME IMMATURITY OR RESPIRATORY DISTRESS SYNDROME NEONATE	$40,300	$24,180	—	—	6
J9223	lurbinectedin 4 mg Pow [ECHA]	$39,798	$23,879	—	—	5
J9301	obinutuzumab 25 mgmL Sol [ECHA]	$38,725	$23,235	—	—	5
J9299	nivolumab 240 mg24 ml Sol [ECHA]	$37,758	$22,655	—	—	5
J2506	PEGFILGRASTIM 6 MG 0.6 ML	$37,386	$22,432	—	—	5
329	MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MCC	$37,251	$22,350	—	—	6
J3380	VEDOLIZUMAB 300 MG 1 EA [ECHA]	$36,585	$21,951	—	—	5
728	INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITHOUT MCC	$35,243	$21,146	—	—	6
J3101	TENECTEPLASE 50 MG 1 EA [ECHA]	$35,171	$21,103	—	—	15
853	INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MCC	$30,743	$18,446	—	—	6
J9306	PERTUZUMAB EA 420 MG 14 ML [ECHA]	$30,075	$18,045	—	—	5
793	FULL TERM NEONATE WITH MAJOR PROBLEMS	$28,540	$17,124	—	—	6
791	PREMATURITY WITH MAJOR PROBLEMS	$27,807	$16,684	—	—	6
J0717	certolizumab 200 mgmL Kit[ECHA]	$27,782	$16,669	—	—	5
J1459	IMMUNE GLOBULIN HUMAN PRIVIGEN 10% INTRAVENOUS 40 GM 400 ML [ECHA]	$26,640	$15,984	—	—	5
Q5115	riTUXimab abbs 500 mg 50mL Sol [ECHA]	$25,367	$15,220	—	—	5
J9271	PEMBROLIZUMAB EA 100 MG 4 ML [ECHA]	$25,341	$15,204	—	—	5
673	OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MCC	$25,182	$15,109	—	—	6
Q5108	pegfilgrastimEAjmdb 6 mg0.6 mL	$25,050	$15,030	—	—	5
J2353	OCTREOTIDE ACETATE 30 MG 1 EA [ECHA]	$24,431	$14,659	—	—	10
335	PERITONEAL ADHESIOLYSIS WITH MCC	$24,375	$14,625	—	—	6
J9177	enfortumab vedotinEAejfv 30 mg Pow [ECHA]	$23,856	$14,314	—	—	5
987	NONEXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC	$23,072	$13,843	—	—	6
J1162	DIGOXIN IMMUNE FAB OVINE 40 MG 1 EA [ECHA]	$21,834	$13,100	—	—	5
J0597	C1 esterase inhibitor Berinert human 500 intl units Kit	$21,724	$13,034	—	—	5
Q5119	riTUXimab pvvr 500 mg50ml Sol [ECHA]	$21,504	$12,902	—	—	5
415	CHOLECYSTECTOMY EXCEPT BY LAPAROSCOPE WITHOUT C.D.E. WITH CC	$21,323	$12,794	—	—	6
J1306	Inclisiran 284 mg1.5 mL Sol	$20,240	$12,144	—	—	5
817	OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURE WITH MCC	$19,396	$11,637	—	—	6
240	AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS EXCEPT UPPER LIMB AND TOE WITH CC	$19,346	$11,607	—	—	6
J9207	IXABEPILONE ONC 340EAB 45 MG 1 EA [ECHA]	$18,942	$11,365	—	—	5
208	RESPIRATORY SYSTEM DIAGNOSIS WITH VENTILATOR SUPPORT greater thanor equal to96 HOURS	$18,654	$11,192	—	—	6
981	EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC	$18,194	$10,916	—	—	6
J9354	ADOEATRASTUZUMAB EMTANSINE 100 MG 1 EA [ECHA]	$17,927	$10,756	—	—	5
84154	Free PSA	$17,867	$10,720	—	—	6
G0372	90375 Rabies immune globulin Igg	$17,867	$10,720	—	—	1
982	EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC	$17,223	$10,334	—	—	6

Showing top 50 of 2,637 priced procedures, sorted by gross charge.

Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.